Sign in Sign Up Free

Cormorant Asset Management, LP

Activist investor & 5%+ owner · SC 13D/13G filings

Total Filings

44

Stocks Covered

26

Latest Filing

Feb 17, 2026

Filings

BioAge Labs, Inc.

SC 13G/A · Feb 17, 2026

5.7%

2.0M shares

Rapport Therapeutics, Inc.

SC 13G/A · Feb 17, 2026

6.3%

3.0M shares

MoonLake Immunotherapeutics

SC 13G · Feb 17, 2026

6.1%

4.4M shares

enGene Holdings Inc.

SC 13G · Feb 17, 2026

6.0%

4.0M shares

Cabaletta Bio, Inc.

SC 13G/A · Feb 17, 2026

9.3%

9.4M shares

Bright Minds Biosciences Inc.

SC 13G/A · Feb 6, 2026

10.9%

1.1M shares

Corbus Pharmaceuticals Holdings, Inc.

SC 13G/A · Dec 15, 2025

13.4%

2.3M shares

EyePoint Pharmaceuticals, Inc.

SC 13G/A · Dec 8, 2025

10.0%

8.3M shares

Corbus Pharmaceuticals Holdings, Inc.

SC 13G/A · Nov 14, 2025

12.8%

2.4M shares

Cabaletta Bio, Inc.

SC 13G/A · Nov 14, 2025

10.0%

9.6M shares

VYNE Therapeutics Inc.

SC 13G/A · Nov 14, 2025

0.0%

0 shares

Rapport Therapeutics, Inc.

SC 13G/A · Nov 14, 2025

6.7%

3.2M shares

Praxis Precision Medicines, Inc.

SC 13G/A · Nov 14, 2025

4.0%

1.0M shares

KALA BIO, Inc.

SC 13G/A · Nov 14, 2025

0.0%

0 shares

iBio, Inc.

SC 13G · Nov 14, 2025

10.0%

2.2M shares

VYNE Therapeutics Inc.

SC 13G/A · Aug 14, 2025

8.2%

1.4M shares

Praxis Precision Medicines, Inc.

SC 13G/A · Aug 14, 2025

7.7%

1.6M shares

Cabaletta Bio, Inc.

SC 13G · Aug 14, 2025

5.5%

5.0M shares

BioAge Labs, Inc.

SC 13G/A · Aug 14, 2025

6.0%

2.1M shares

VYNE Therapeutics Inc.

SC 13G/A · May 19, 2025

10.0%

1.8M shares

OnKure Therapeutics, Inc.

SC 13G/A · May 19, 2025

0.0%

0 shares

VYNE Therapeutics Inc.

SC 13G/A · May 15, 2025

0.0%

0 shares

Praxis Precision Medicines, Inc.

SC 13G/A · May 15, 2025

8.6%

1.7M shares

CARGO Therapeutics, Inc.

SC 13G · May 15, 2025

7.3%

3.4M shares

Praxis Precision Medicines, Inc.

SC 13G/A · Feb 14, 2025

9.1%

1.7M shares

KALA BIO, Inc.

SC 13G · Feb 14, 2025

10.0%

609K shares

BioAge Labs, Inc.

SC 13G · Feb 14, 2025

7.3%

2.6M shares

Rapport Therapeutics, Inc.

SC 13G/A · Nov 14, 2024

8.0%

2.9M shares

Longboard Pharmaceuticals, Inc.

SC 13G/A · Nov 14, 2024

8.1%

2.8M shares

EyePoint Pharmaceuticals, Inc.

SC 13G/A · Nov 14, 2024

12.2%

8.3M shares

Corbus Pharmaceuticals Holdings, Inc.

SC 13G/A · Nov 14, 2024

19.5%

2.4M shares

Praxis Precision Medicines, Inc.

SC 13G/A · Nov 14, 2024

4.7%

870K shares

Ventyx Biosciences, Inc.

SC 13G/A · Nov 14, 2024

0.0%

0 shares

TScan Therapeutics, Inc.

SC 13G/A · Nov 14, 2024

0.0%

0 shares

Tarsus Pharmaceuticals, Inc.

SC 13G/A · Nov 14, 2024

1.3%

500K shares

Neurogene Inc.

SC 13G/A · Nov 14, 2024

0.8%

107K shares

MARINUS PHARMACEUTICALS, INC.

SC 13G/A · Nov 14, 2024

0.0%

0 shares

Korro Bio, Inc.

SC 13G/A · Nov 14, 2024

2.9%

266K shares

Immuneering Corporation

SC 13G/A · Nov 14, 2024

0.0%

0 shares

CytomX Therapeutics, Inc.

SC 13G/A · Nov 14, 2024

0.0%

0 shares

ALX ONCOLOGY HOLDINGS INC.

SC 13G/A · Nov 14, 2024

0.0%

0 shares

Bright Minds Biosciences Inc.

SC 13G/A · Nov 6, 2024

17.3%

1.1M shares

VectivBio Holding AG

SC 13G · Jun 17, 2022

6.2%

2.2M shares

Tango Therapeutics, Inc.

SC 13G · Feb 14, 2022

5.6%

4.9M shares